Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.42 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.42 |
| ▸ | ALDH1A3 | P47895 | 3/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALDH3A1 | P30838 | 4/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16731702 | 0.83 | ALDH1A3 (0.46) | ALDH1A1KDM4EMAPTGAACYP2A6 | |
| SCHEMBL2292105 | 0.79 | ALDH3A1 (0.61) | ALDH1A1MAPTALDH1A3TSHRALDH3A1 | |
| SCHEMBL13123401 | 0.79 | XDH (0.42) | ALDH1A1KDM4EMAPTGAAXDH | |
| SCHEMBL6899726 | 0.77 | ALDH1A1 (0.47) | ALDH1A1KDM4ECYP2A6TSHREGFR | |
| SCHEMBL27694001 | 0.77 | CYP2A6 (0.52) | ALDH1A1KDM4ECYP2A6CYP2A13ALDH1A3 | |
| SCHEMBL29956523 | 0.76 | TSHR (0.43) | ALDH1A1KDM4ECYP2A6ALDH1A3TSHR | |
| SCHEMBL6435855 | 0.76 | TSHR (0.43) | ALDH1A1KDM4ECYP2A6ALDH1A3TSHR | |
| SCHEMBL26969028 | 0.74 | CYP2A6 (0.51) | ALDH1A1KDM4EMAPTCYP2A6CYP2A13 | |
| SCHEMBL30893368 | 0.73 | ALDH1A3 (0.49) | ALDH1A1KDM4ECYP2A6CYP2A13ALDH1A3 | |
| SCHEMBL31299760 | 0.73 | CYP2A6 (0.48) | ALDH1A1KDM4ECYP2A6CYP2A13ALDH1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118061627-A | High-temperature-resistant fabric and preparation method thereof | 上海晶芙化工科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-120287685-A | Preparation method of high-temperature-resistant fabric | 上海晶芙化工科技有限公司 | 2025-07-11 | — | — | CN | disclosed |
| CN-118061627-A | High-temperature-resistant fabric and preparation method thereof | 上海晶芙化工科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118061627-A | High-temperature-resistant fabric and preparation method thereof | 上海晶芙化工科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-3606921-B1 | NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA. | INVENTIVA (FR) | 2022-06-01 | — | — | EP | disclosed |
| CN-108341799-B | Novel indole derivatives for the treatment of cancer, viral infections and lung diseases | 生物控制术公司 | 2022-01-25 | — | — | CN | disclosed |
| US-10851054-B2 | Derivatives of indole for the treatment of cancer, viral infections and lung diseases | BIOKINESIS (FR) | 2020-12-01 | — | — | US | disclosed |
| US-20200115353-A1 | NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA | INVENTIVA (FR) | 2020-04-16 | — | — | US | disclosed |
| EP-3606921-A1 | NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA. | Inventiva (FR) | 2020-02-12 | — | — | EP | disclosed |
| US-20170233342-A1 | NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES | DIACCURATE (FR) | 2017-08-17 | — | — | US | disclosed |
| US-9643923-B2 | Derivatives of indole for the treatment of cancer, viral infections and lung diseases | BIOKINESIS (FR) | 2017-05-09 | — | — | US | disclosed |
| US-20150307450-A1 | NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-10-29 | — | — | US | disclosed |
| EP-2928864-A1 | NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES | Biokinesis (FR) | 2015-10-14 | — | — | EP | disclosed |
| US-9023998-B2 | Near infrared fluorogen and fluorescent activating proteins for in vivo imaging and live-cell biosensing | CARNEGIE MELLON UNIVERSITY (US) | 2015-05-05 | — | — | US | disclosed |
| US-20140243509-A1 | NEAR INFRARED FLUOROGEN AND FLUORESCENT ACTIVATING PROTEINS FOR IN VIVO IMAGING AND LIVE-CELL BIOSENSING | CARNEGIE MELLON UNIVERSITY | 2014-08-28 | — | — | US | disclosed |
| WO-2014086964-A1 | NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES | BIOKINESIS (FR) | 2014-06-12 | — | — | WO | disclosed |
| EP-1534676-B1 | PIPERIDINETRIOL DERIVATIVES AS INHIBITORS OF GLYCOSYLCERAMIDE SYNTHASE | ACTELION PHARMACEUTICALS LTD (CH) | 2012-09-12 | — | — | EP | disclosed |
| EP-1534676-A1 | PIPERIDINETRIOL DERIVATIVES AS INHIBITORS OF GLYCOSYLCERAMIDE SYNTHASE | Oxford GlycoSciences (UK) Limited (GB) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004007453-A1 | PIPERIDINETRIOL DERIVATIVES AS INHIBITORS OF GLYCOSYLCERAMIDE SYNTHASE | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140243509-A1 | NEAR INFRARED FLUOROGEN AND FLUORESCENT ACTIVATING PROTEINS FOR IN VIVO IMAGING AND LIVE-CELL BIOSENSING | FUCA1, TYR, HBG2 | ALDH1A1 1815/4885KDM4E 3374/4885MAPT 2589/4885 |
| US-20150307450-A1 | NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES | IDO2, IDO1, ING2 | ALDH1A1 2891/4885KDM4E 1505/4885MAPT 3437/4885 |
| US-20170233342-A1 | NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES | IDO2, IDO1, ING2 | ALDH1A1 2891/4885KDM4E 1505/4885MAPT 3437/4885 |
| US-20200115353-A1 | NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA | YAP1, TEAD2, TEAD1 | ALDH1A1 3397/4885KDM4E 1436/4885MAPT 1811/4885 |
| US-10851054-B2 | Derivatives of indole for the treatment of cancer, viral infections and lung diseases | IDO2, IDO1, ING2 | ALDH1A1 2533/4885KDM4E 1237/4885MAPT 3706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.